The metabolic syndrome: prevalence in worldwide populations.
about
A comprehensive review on metabolic syndromeFenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]Predictors of Inadequate Bowel Preparation and Salvage Options on ColonoscopyCurrent perspectives between metabolic syndrome and cancerEffect of cardiac rehabilitation on metabolic syndrome and its components: A systematic review and meta-analysisInsulin-like growth factor-1 deficiency and metabolic syndromeMetabolic Syndrome and the LungPrevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factorsBiochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in miceHeterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations.Overview of the metabolic syndrome; an emerging pandemic of public health significance.Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study.Cationic Polystyrene Resolves Nonalcoholic Steatohepatitis (NASH), Obesity, and Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and Decreasing Endotoxemia.Heritability of metabolic syndrome traits in a large population-based sample.Autophagy is involved in adipogenic differentiation by repressesing proteasome-dependent PPARĪ³2 degradationProtocol for an experimental study design to evaluate computer-enabled intervention to prevent and manage metabolic syndromeMetabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity.Metabolic syndrome in a Taiwanese metropolitan adult population.Gender, socio-economic status and metabolic syndrome in middle-aged and old adultsAging, female sex, migration, elevated HDL-C, and inflammation are associated with prevalence of metabolic syndrome among African bank employees.Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study.The metabolic syndromeThe relationship between physical activity and metabolic syndrome in people with chronic obstructive pulmonary disease.Relationship between Metabolic Syndrome Components and Periodontal Disease in a Japanese General Population: the Suita Study.Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components.Using principal component analysis to develop a single-parameter screening tool for metabolic syndromeIncidence and risk factors of deep venous thrombosis following arthroscopic posterior cruciate ligament reconstructionPrevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study(-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress.Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians.The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data.The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh.The effect of salsalate on biochemical factors and endothelial dysfunction of prediabetic patients: A randomized clinical trialValidation of metabolic syndrome using medical records in the SUN cohortMetabolic syndrome in young Asian Indian patients with myocardial infarctionMetabolic Syndrome and Its Components: Secondary analysis of the World Health Survey, Oman.Association of glycosylated hemoglobin (HbA1c) levels with Iinsulin resistance in obese children.Ethnic differences in the prevalence of metabolic syndrome: results from a multi-ethnic population-based survey in Malaysia.High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome.
P2860
Q21284500-ABD511BC-1DB8-4D3F-8BAB-7EBB050891BCQ24815913-49568600-E54A-4ACA-895E-DA1BB15EBC1BQ26739926-7349B1B9-E151-4262-AF7F-F9C90253173AQ26749299-390E5459-50FA-43F9-86B0-FE4B1FB4BD68Q28069972-C7EB4EB9-02AA-47D3-9899-140ED609714CQ28072410-CCFBA542-3171-4C00-8E5F-E1D145C974F8Q28384152-8B463442-960A-49FA-B6D9-431BFF66E972Q28396378-71CEC6F8-8931-429E-8ADC-A59426F9222CQ28468601-D9F5D9CD-85BF-4174-8270-07C9514D7E31Q29353804-9DE9BD9F-D40C-4B3A-A190-E4E641B0E745Q30366107-4EC6BF22-DA56-4138-A9C8-F89F26EC2C3BQ30396880-CE51CDA5-708B-4455-A3FE-5B2F9AB0F70BQ30401402-4F6928FF-CDC9-4F7A-AB17-2EFFB71E471AQ30410470-7D7B8A8A-3035-45D8-8BE3-AB6CDC256A1BQ30456765-4ACD8170-485C-4385-A3FD-A524F8CE5649Q30538218-EEAEE875-346D-40E0-B32F-9BE644337140Q30570152-1EEA4217-8D0C-4AE7-A1F3-DA014710E5CBQ30620489-8BC1A8AB-8D1B-4501-84A0-7667D6A0AFF1Q33298695-FC7F2A4A-2F18-427D-80A6-B00369D68533Q33320219-B42093A6-33E6-4F5F-A26F-C197209498EDQ33454936-AA78D990-61F0-4EEE-AA90-6F0C35693E82Q33525176-7D9ECC81-DBE1-4E30-BA90-F5DCFC6BBF14Q33569142-7C0A45B2-6E31-4AC2-905F-69BD756DBCF9Q33655398-21B0E2B1-D658-4859-B3E0-E75CE0C7CAB1Q33675990-A28CADFD-E37B-44E2-AF4C-8D7B01BDC05CQ33742916-AEA191B7-BFDA-4CD5-B7D9-91750AD0BDF1Q33749054-B4E06B1C-54A6-4EC6-8C8C-7D39AB01066CQ33765593-B6C2690B-FF7A-41C7-9065-8DBD571B0622Q33785378-DF8D7F28-CB5E-4640-B57E-B4EAEE05A668Q33830374-742A34B3-B424-4266-8FB6-63EE4C406898Q33867976-9BF11CF6-55CD-4193-8F99-4A3062BAA5ACQ33889954-7B2A6D36-08BF-439E-ABF3-4D84FD748CDEQ33940508-83B333E6-FA54-437A-A611-3EA9A78DB050Q33970976-CFB83FD9-280F-4AE3-9A52-F961B7DD9EDFQ34074813-7C9C7C7A-E50E-48C7-91DE-B59A9C01202DQ34220041-8BD6E551-7B99-4253-8B1D-705BEB56731FQ34380554-EB86447D-266D-41F8-8E75-25D844A5EF86Q34405607-061C2D68-50DE-42E0-9FEA-175F11CD0DBCQ34431149-5D45DFE6-18C3-4F3E-B833-790E72FE1678Q34437265-C4147B75-B178-40CC-B01D-60BF82A6AB2C
P2860
The metabolic syndrome: prevalence in worldwide populations.
description
2004 nĆ® lÅ«n-bĆ»n
@nan
2004幓ć®č«ę
@ja
2004幓č«ę
@yue
2004幓č«ę
@zh-hant
2004幓č«ę
@zh-hk
2004幓č«ę
@zh-mo
2004幓č«ę
@zh-tw
2004幓č®ŗę
@wuu
2004幓č®ŗę
@zh
2004幓č®ŗę
@zh-cn
name
The metabolic syndrome: prevalence in worldwide populations.
@ast
The metabolic syndrome: prevalence in worldwide populations.
@en
type
label
The metabolic syndrome: prevalence in worldwide populations.
@ast
The metabolic syndrome: prevalence in worldwide populations.
@en
prefLabel
The metabolic syndrome: prevalence in worldwide populations.
@ast
The metabolic syndrome: prevalence in worldwide populations.
@en
P1476
The metabolic syndrome: prevalence in worldwide populations.
@en
P2093
Jonathan E Shaw
Paul Z Zimmet
P304
351-75, table of contents
P356
10.1016/J.ECL.2004.03.005
P577
2004-06-01T00:00:00Z